Sumitra Gupta (@biotechsumitra) 's Twitter Profile
Sumitra Gupta

@biotechsumitra

Corporate Development @ArenaPharm

ID: 855138654678769664

calendar_today20-04-2017 19:18:37

505 Tweet

198 Followers

273 Following

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

.Elon Musk says, "if you don't love [your product], don't expect others will either." I wonder what #biopharma would look like if we applied that mindset. Not just thinking about target product profiles, but whether YOU would use & love the drug. The Wall Street Journal: youtube.com/watch?v=V1nQFo…

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

The first half of this video (through 5:57) provides a stellar explanation of CYP inhibition and induction #pharmacokinetics #metabolism youtube.com/watch?v=OhIopf…

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

Mic drop @LindaDSierra! Had to share. Because experience and credentials aren’t enough? #biotech #pharma #DiversityandInclusion #WomenInSTEM

Mic drop @LindaDSierra! Had to share. Because experience and credentials aren’t enough? #biotech #pharma #DiversityandInclusion #WomenInSTEM
MacDougall Advisors (@macdougallbio) 's Twitter Profile Photo

#JPM2021 begins next week. Check out the free #JPM2021 Guide that MacDougall and BioCentury put together: bit.ly/3qfdNUK #JPM21 #Biotechshowcase #healthcarepartneringweek Pharmaceutical #JPMGuide

#JPM2021 begins next week. Check out the free #JPM2021 Guide that MacDougall and <a href="/BioCentury/">BioCentury</a> put together: bit.ly/3qfdNUK  #JPM21 #Biotechshowcase #healthcarepartneringweek <a href="/Pharmaceutical/">Pharmaceutical</a> #JPMGuide
Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

.Anne Wojcicki on Follow @Clubhouse: "[The unwritten rule is that patients don't change their behavior. There is an opportunity to prevent, but it is more complicated than just pointing out the problem. This is where the phone becomes very valuable and provides a continuum of care.]"

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

.Anne Wojcicki regarding the future of healthcare: "[You can't innovate from within because the system makes so much money on inefficiency. The question is who is going to make money on being 95 years old and disease free?]"

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

Yesterday, we announced a strategic collaboration to advance the clinical development of RIST4721, an oral CXCR2 antagonist being developed by Aristea for the treatment of palmoplantar pustulosis (PPP) and other neutrophil-mediated diseases. $ARNA invest.arenapharm.com/news-releases/…

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

We’ve initiated a strategic collaboration with Second Genome to identify microbiome biomarkers in our Phase 2/3 Crohn’s program. #ArenaPharm #ARNA

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

Do they really? Not according to Bloomberg. "65% of workers who said their jobs could be done entirely remotely were willing to take a 5% reduction to stay at home." bloomberg.com/news/articles/…

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

“[…we equate #leadership with the psychological features that make the avg. man a more inept leader than the avg. woman. This results in a pathological system that rewards men for their incompetence while punishing women for their competence.]” hbr-org.cdn.ampproject.org/c/s/hbr.org/am…

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

Agree. It seems there is imaginary red tape creating inefficiencies in all systems, esp. healthcare. It is exceptionally difficult for the elderly who don’t have children to support them/family living close by.

Sumitra Gupta (@biotechsumitra) 's Twitter Profile Photo

Top Ten Cognitive Optical Illusions in Clinical Research. Great read and goes to show why most Phase 3's don't succeed after failed Phase 2's. “If you torture the data long enough, it will confess to anything.” #clinicaltrials #research clinicaltrialist.files.wordpress.com/2017/11/cognit…

Jake Becraft (@drsynbio) 's Twitter Profile Photo

A ridiculously ignorant viewpoint here that is sadly common among policy makers. NIH funding sometimes helps create early technology but industry is providing the vast majority of innovative translational science.

Albert Bourla (@albertbourla) 's Twitter Profile Photo

Pfizer’s committed to addressing unmet needs across a number of diseases. We’re happy to announce an agreement to acquire @ArenaPharm, a company developing innovative potential therapies in gastroenterology, dermatology & cardiology: on.pfizer.com/3ysuRuX